Content
Cresco Labs Q4 Report Shows Major Improvement In Net Profit
Article By:
Lorimer Wilson
Read
Monday, March 18, 2024 4:21 PM EDT
Cresco Labs' financial results show considerable improvement in Adjusted EBITDA, a Net Profit turnaround.
In this article: CRLBF
What Caused Humana’s Shocking Earnings Miss?
Video By:
Chuck Carnevale
Watch
Monday, March 18, 2024 1:31 PM EDT
Humana missed estimates dramatically for the 4th quarter of last year and analysts have now cut their forecast for 2024 virtually in half.
In this video: HUM
"Freaky Friday" Startled Our American Cannabis MSO Index, In A Good Way
Article By:
Lorimer Wilson
Read
Sunday, March 17, 2024 9:08 PM EDT
Last Friday the trading volume in the 7 stocks in our American Cannabis MSO Stocks Index was 51.5% higher than the average daily trading volume. Pricewise, the Index was up almost 15%.
10 Big-Name Stocks Near 52-Week Lows: Are They A Buy?
Article By:
Tobias Carlisle
Read
Friday, March 15, 2024 11:30 PM EDT
Over the past twelve months a number of big named companies have been near or below their 52 week low price. Each week we’ll take a look at some of the biggest names currently close to their 52 week lows.
Q4 Financials Of Cannabis MSO, TerrAscend, Were Terrible
Article By:
Lorimer Wilson
Read
Friday, March 15, 2024 1:04 PM EDT
Management claims that TerrAscend has the right team, assets, cash flow, and ample greenfield opportunities to pursue additional growth in 2024 by capitalizing on the current environment and entering into attractive states on accretive terms.
In this article: TSNDF
Current Analysis: H. Lundbeck
Article By:
Fredrik Arnold
Read
Friday, March 15, 2024 3:20 AM EDT
H. Lundbeck (HLUBF) is a Denmark-based pharmaceutical firm. Over the past year, Lundbeck's share price rose 15%.
Current Analysis: MediPal Holdings
Article By:
Fredrik Arnold
Read
Friday, March 15, 2024 12:30 AM EDT
MediPal Holdings Corp. distributes pharmaceuticals and health and beauty products to medical institutions and retailers.
In this article: MAHLY
Cannabis MSO Ayr Wellness Reports Q4 Increase In Net Loss Of 53%
Article By:
Lorimer Wilson
Read
Thursday, March 14, 2024 4:00 PM EDT
Ayr Wellness Inc. reported financial results for the fourth quarter ended December 31, 2023 today.
In this article: AYRWF
Bear Of The Day: AMN Healthcare Services
Article By:
Zacks Investment Research
Read
Thursday, March 14, 2024 10:58 AM EDT
Labor shortages and staff burnout among nurses are reasons to be wary of AMN Healthcare Services (AMN) stock despite the company’s favorable long-term prospects.
In this article: AMN
Q4 Financials Of Cannabis MSO, Curaleaf, Show Improvement Across The Board
Article By:
Lorimer Wilson
Read
Thursday, March 14, 2024 6:30 AM EDT
Curaleaf management reports that the work the company has done over the past several quarters paid off in Q4, and that global opportunities are unfolding rapidly as expected.
In this article: CURLF
Reviving Interest: Moderna
Article By:
Tim Knight
Read
Wednesday, March 13, 2024 9:50 PM EDT
Here’s a stock I haven’t thought about in a long time: Covid-mega-beneficiary Moderna, which seems to have a rock-solid price sealing at about $118.
In this article: MRNA
Current Analysis: Haleon
Article By:
Fredrik Arnold
Read
Tuesday, March 12, 2024 7:30 PM EDT
Haleon (HLN) is one of the largest consumer health companies in the world. Over the past year, Haleon PLC share price rose 13.8% from $7.60 to $8.66 as of Tuesday’s market close.
In this article: HLN
In A Free Market, Drugs Are Cheap, Government Policies Make Them Expensive
Article By:
Dean Baker
Read
Tuesday, March 12, 2024 5:47 AM EDT
We will spend well over $600 billion this year on drugs. These drugs would likely cost less than $100 billion in a free market.
Current Analysis: Getinge AB
Article By:
Fredrik Arnold
Read
Monday, March 11, 2024 7:35 PM EDT
Getinge AB, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences. Over the past year, Getinge AB share price fell 0.08% from $20.36 to $20.20 as of Monday’s market close.
In this article: GNGBY